Mogamulizumab-kpkc and Orphenadrine Citrate
Determining the interaction of Mogamulizumab-kpkc and Orphenadrine Citrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc-Orphenadrine Extended-Release Tablets
- Mogamulizumab-kpkc-Orphenadrine Injection
- Mogamulizumab-kpkc-Orphenadrine w/A.C.
- Mogamulizumab-kpkc-Orphenadrine, aspirin, and caffeine
- Mogamulizumab-kpkc-Orphenate
- Mogamulizumab-kpkc-Orphengesic
- Orphenadrine Citrate-Mogamulizumab-kpkc Intravenous
- Orphenadrine Citrate-Molindone
- Orphenadrine Citrate-Mometasone (Oral Inhalation)
- Orphenadrine Citrate-Mometasone and Formoterol
- Orphenadrine Citrate-Mometasone and formoterol Inhalation
- Orphenadrine Citrate-Mometasone Cream